【礼来在印度推出减肥药Mounjaro 击败诺和诺德占领主要市场】礼来公司于周四在印度推出了糖尿病和减肥药物Mounjaro,击败竞争对手诺和诺德,进入世界第一人口大国,印度目前正努力应对其国内肥胖和糖尿病发病率不断上升的问题。美国礼来公司以及丹麦诺和诺德公司的创新减肥药物在全球需求猛增,投资者的兴趣也推高了制药商的估值。

金融界
22 Mar
礼来公司于周四在印度推出了糖尿病和减肥药物Mounjaro,击败竞争对手诺和诺德,进入世界第一人口大国,印度目前正努力应对其国内肥胖和糖尿病发病率不断上升的问题。美国礼来公司以及丹麦诺和诺德公司的创新减肥药物在全球需求猛增,投资者的兴趣也推高了制药商的估值。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10